The gradual increases made the transition smoother than I expected and by 4 mg my appetite was noticeably quieter
[1] [2] Whilst these mechanisms contribute to improved glycaemic control and weight reduction, they also account for one of the most commonly reported adverse effects: nausea
It's important to note that hair loss (alopecia) is listed as an adverse reaction in the Summary of Product Characteristics (SmPC) for semaglutide 2.4 mg (Wegovy), though it is not listed as a common side effect for other GLP-1 medications such as Ozempic, Saxenda, or Trulicity
Starting too early may increase the risk of nausea, vomiting, or complications as your body adapts to both reduced volume and medication-induced appetite suppression simultaneously
After 40 weeks, tirzepatide significantly outperformed placebo in both glycemic control and weight loss
Liver enzymes, such as serum aminotransferases, commonly elevate in fatty liver disease, indicating stress or damage